A new CAR T-cell therapy designed to treat gastric (stomach) and pancreatic cancers will soon be available to patients in China, according to Jiahui International…
Pancreatic cancer
PANCREATIC CANCER
Electrical therapy shows promise for metastatic pancreatic cancer
A type of electrical therapy called Tumor Treating Fields (TTFields), given in combination with chemotherapy and other medication, may help prevent disease progression in people…
Adding Amplia Therapeutics‘ experimental drug narmafotinib to standard chemotherapy led to complete responses — meaning no detectable cancer on imaging scans for at least…
PANCREATIC CANCER
New AI-based tool aims to help guide treatment for pancreatic cancer
Caris Life Sciences has launched a new diagnostic tool that aims to help guide treatment decisions for people with pancreatic ductal adenocarcinoma (PDAC), the…
PANCREATIC CANCER
Ketogenic diet with chemo shows survival trend in pancreatic cancer
People with advanced pancreatic cancer who followed a ketogenic diet program administered by Virta Health while receiving chemotherapy tended to live longer than…
PANCREATIC CANCER
Experimental therapy outperforms approved treatment in PNET trial
The experimental therapy 177Lu-edotreotide outperformed the approved treatment everolimus in prolonging progression-free survival in people with pancreatic neuroendocrine tumors (PNETs), according to a new…
A new blood test powered by artificial intelligence (AI) could offer a life-saving head start for patients at high risk of pancreatic cancer.
PANCREATIC CANCER
Pancreatic cancer growth tied to cells’ self-eating process
A cellular recycling process called autophagy helps determine whether pancreatic cancer cells grow quickly or hunker into survival mode to resist treatment, a study…
PANCREATIC CANCER
FDA approves electrical field therapy Optune Pax for pancreatic cancer
The U.S. Food and Drug Administration (FDA) has approved Novocure’s Optune Pax, a type of Tumor Treating Fields (TTFields) therapy, as a treatment for…
PANCREATIC CANCER
FDA gives green light to first human trial testing cancer drug GTB-5550
A first-in-human clinical trial will launch in the coming months to test GTB-5550, an immune therapy from GT Biopharma that’s designed to treat various types…
Recent Posts
- Zoldonrasib trial aims to extend survival in advanced pancreatic cancer
- When the mirror talks back: Facing my own changing body and health
- Early use of electrical device doesn’t extend glioblastoma survival
- Targeted drug shrinks hard-to-treat ovarian tumors, early data show
- US patients gain new generic drug option for myeloma treatment
